# Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients

> **NCT00447967** · PHASE2 · COMPLETED · sponsor: **Hellenic Oncology Research Group** · enrollment: 110 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Irinotecan
- **DRUG:** Oxaliplatin
- **DRUG:** Fluorouracil
- **DRUG:** Leucovorin
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT00447967
- **Lead sponsor:** Hellenic Oncology Research Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2009-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00447967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00447967, "Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00447967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*